课题基金 / 基金详情

Multilevel factors for racial/ethnic and socioeconomic disparities in prognosis of hepatocellular carcinoma

Multilevel factors for racial/ethnic and socioeconomic disparities in prognosis of hepatocellular carcinoma
肝细胞癌预后中种族/民族和社会经济差异的多层次因素
批准号:
10427946
负责人:
Amit Singal
金额:
$9.36万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-04-03 至 2024-11-30

项目摘要

项目成果

Amit Singal的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Hepatocellular carcinoma (HCC) is the fastest growing cause of cancer-related death in the U.S. HCC disproportionally affects racial/ethnic minority and socioeconomically disadvantaged populations, with higher age-adjusted mortality observed in non-Hispanic blacks and Hispanic whites than non-Hispanic whites. To evaluate these disparities, we will use an adapted Warnecke/Centers for Population Health and Health Disparities ecological multi-level model attributing disparate health outcomes to biological-environmental interactions between and across distal (population social conditions and policies), intermediate (social and physical contexts including social relationships), and proximal (individual demographics and biological responses) determinants. Applying this model to HCC disparities will facilitate identification of key drivers of disparities in prognosis, which is the first necessary step to develop intervention strategies aimed at improving survival and reducing disparities following HCC diagnosis. Specifically, our proposal will characterize the contribution of proximal, intermediate, and distal determinants to disparities in 3 known measures of HCC prognosis: a) tumor stage at diagnosis, b) receipt of timely and guideline-concordant HCC treatment, and c) overall survival. Leveraging existing clinical databases and a biorepository of stored serum, we will conduct a multi-center study using electronic medical record-derived, patient-reported, provider-reported, and serum- based biological factors in a cohort of ~5000 patients newly diagnosed with HCC over a 13-year period to: Aim 1: Characterize the contribution of proximal, intermediate, and distal determinants of racial/ethnic and socioeconomic disparities in HCC tumor stage at diagnosis Aim 2: Determine racial/ethnic and socioeconomic disparities in receipt of timely and guideline- concordant HCC treatment including proximal, intermediate, and distal determinants Aim 3: Identify proximal, intermediate, and distal determinants of racial/ethnic and socioeconomic disparities in overall survival following HCC diagnosis Overall, we will identify factors across and within multiple levels associated with disparities in HCC prognosis between non-Hispanic white, Hispanic white, and non-Hispanic black patients as well as low versus high SES class in a large, racial/ethnically and socioeconomically diverse diverse cohort of ~5000 HCC patients. Our study will provide an understanding of why HCC prognosis disparities exist and at what level interventions should be implemented to reduce disparities improving overall survival.
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
The quest for precision oncology with immune checkpoint inhibitors for hepatocellular carcinoma.
寻求针对肝细胞癌的免疫检查点抑制剂的精准肿瘤学。
DOI: 10.1016/j.jhep.2021.11.021
发表时间: 2022
期刊: Journal of hepatology
影响因子: 25.7
作者: [Cabibbo,Giuseppe, Singal,AmitG]
通讯作者: Singal,AmitG
DOI: 10.1002/hep4.1863
发表时间: 2022-05
期刊: HEPATOLOGY COMMUNICATIONS
影响因子: 5.1
作者: [Wagle, Nikita Sandeep, Park, Sulki, Washburn, David, Ohsfeldt, Robert L., Rich, Nicole E., Singal, Amit G., Kum, Hye-Chung]
通讯作者: Kum, Hye-Chung
DOI: 10.1097/hc9.0000000000000162
发表时间: 2023-06-01
期刊: Hepatology communications
影响因子: 5.1
作者: []
通讯作者:
DOI: 10.1002/hep4.1795
发表时间: 2022-01
期刊: Hepatology communications
影响因子: 5.1
作者: [Govalan R, Luu M, Lauzon M, Kosari K, Ahn JC, Rich NE, Nissen N, Roberts LR, Singal AG, Yang JD]
通讯作者: Yang JD
25
    Precision Risk Stratification and Screening for HCC among Patients with Cirrhosis in the United States
    • 批准号:
      10477966
    • 项目类别:
    • 资助金额:
      $71.89万
    • 财政年份:
      2018
    • 负责人:
      Amit Singal
    • 依托单位:
    Precision Risk Stratification and Screening for HCC among Patients with Cirrhosis in the United States
    • 批准号:
      9980310
    • 项目类别:
    • 资助金额:
      $69.3万
    • 财政年份:
      2018
    • 负责人:
      Amit Singal
    • 依托单位:
    Precision Risk Stratification and Screening for HCC among Patients with Cirrhosis in the United States
    • 批准号:
      10225536
    • 项目类别:
    • 资助金额:
      $70.17万
    • 财政年份:
      2018
    • 负责人:
      Amit Singal
    • 依托单位:
    Precision Screening for Hepatocellular Carcinoma in Patients with Cirrhosis
    • 批准号:
      10365950
    • 项目类别:
    • 资助金额:
      $39.91万
    • 财政年份:
      2018
    • 负责人:
      Amit Singal
    • 依托单位:
    国内基金
    海外基金
    补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
    靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
    • 批准号:
      JCZRQN202500010
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位:
    对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
    • 批准号:
      2025JJ70209
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      雷芬芳
    • 依托单位:
    AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      万荣
    • 依托单位: